Minerva Surgical Announces AUB Awareness Day
Minerva calls on women to talk about their periodsSANTA CLARA, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc....
Day: April 26, 2022
Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl)
DUBLIN, Ireland and BRIDGEWATER, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today its partner HLS...
Bioventus Announces $415 Million Offering of Senior Notes
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in...
Galecto Completes Enrollment in Global Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of IPF
GB0139 is Galecto’s proprietary inhaled once-daily small molecule galectin-3 inhibitor GALACTIC-1 trial on track to deliver top-line results in mid-2023...
Marketer with over 20 years of experience selected to head up marketing at Predictive Oncology
Senior Director of Marketing Theresa Ferguson selected as marketing lead for Predictive OncologyEAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) --...
Assure Holdings Further Strengthens Clinical Team with Hiring of James Watt as National Technologist Director
DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...
Agenus to Provide Corporate Update and First Quarter 2022 Financial Report
Conference Call on Tuesday, May 10, 2022 at 8:30 a.m. ETLEXINGTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ:...
ABVC BioPharma Announces Vitargus Phase II Clinical Study Investigator Meeting
FREMONT, CA, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease
PRX012 is a potential best-in-class, subcutaneous anti-amyloid beta antibody therapy currently in a Phase 1 clinical study for the treatment...
Myovant Sciences to Host Fourth Fiscal Quarter and Fiscal Year 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on May 10, 2022
BASEL, Switzerland, April 26, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) today announced it will host a webcast and conference...
SELLAS Life Sciences Launches Expanded Access Program for Galinpepimut-S
Physicians To Have Pre-Approval/Expanded Access to Galinpepimut-S (GPS) for Treatment of Patients with Acute Myeloid Leukemia (AML)NEW YORK, April 26,...
Panbela Schedules Conference Call on May 12, 2022, to Report 2022 First Quarter Financial Results
MINNEAPOLIS, April 26, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
Tarsus Presents Results of Two Studies Highlighting Demodex Blepharitis Patient Impact and Burden at the ASCRS 2022 Annual Meeting
IRVINE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet...
First European Union Patient Dosed with 177Lu-PNT2002 in the Phase 3 SPLASH Trial
POINT Biopharma’s Phase 3 SPLASH trial in pre-chemo metastatic castration-resistant prostate cancer (mCRPC) is now randomizing in the US, Canada,...
Evoke Pharma Granted FDA Market Exclusivity for GIMOTI®
Reinforces Company’s Robust Intellectual Property PortfolioSOLANA BEACH, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a...
Better Choice Company to Host First Quarter 2022 Earnings Call on May 12th at 8:30 a.m. ET
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet...
Quotient Limited Announces Appointment of New Board Member
JERSEY, Channel Islands, April 26, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the...
Vivos Therapeutics Opens Third U.S. Multidisciplinary Center to Treat Patients Suffering from Sleep Apnea with The Vivos Method
New Pneusomnia Center in Toluca Lake, Calif., Will Combine Medical and Dental Expertise to Provide Comprehensive Care for Complex Airway...
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population
Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric...
Codex DNA Demonstrates End-to-End Workflow for Storing and Retrieving Data in Synthetic DNA
Proof-of-concept studies go beyond typical DNA data storage projects to ensure high-fidelity data recovery within an automated synthetic biology workflowSAN...
